In a biotech landscape dominated by billion-dollar IPOs and VC-fueled hype, CARRTECH is playing a different game entirely. This isn't a lab waiting for funding; it's a revenue-generating machine with just 5 people, proving that product-led growth beats fundraising every time.

"They're not building for the boardroom—they're building for the balance sheet. Zero traffic, zero funding, but $800K in revenue tells a powerful story about focus."

The tech stack reveals a pragmatic approach: Squarespace for speed, Google Analytics for measurement, and social profiles for credibility without the overhead of content marketing. Their YouTube video has likely served as a single, targeted asset rather than a content strategy. This is biotech execution at its most disciplined.

• Revenue-per-employee of $160K rivals established biotech firms
• Zero digital footprint suggests proprietary or government contracts
• Social presence is curated, not active—quality over quantity
• Squarespace build indicates lean operations, not tech debt